On November 2, according to Wantai Biotech, recently, the nine-valent HPV vaccine Xinkening® 9, jointly developed by Wantai Biotech's subsidiary Xiamen Wantai Canghai Biotechnology Co., Ltd. and Xiamen University, was officially launched in Thailand. According to data, Citronine® 9 was approved for marketing in China in 2025 and approved by the Thai Food and Drug Administration in 2026. Thailand became its first overseas country to be approved.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.